Bio Green Med Solution, Inc. (BGMS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.005x

Based on the latest financial reports, Bio Green Med Solution, Inc. (BGMS) has a cash flow conversion efficiency ratio of -0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-33.00K) by net assets ($6.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Bio Green Med Solution, Inc. - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Bio Green Med Solution, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Bio Green Med Solution, Inc. debt and liabilities for a breakdown of total debt and financial obligations.

Bio Green Med Solution, Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio Green Med Solution, Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Nippon Active Value Fund Plc
LSE:NAVF
0.009x
Beyond Air Inc
NASDAQ:XAIR
-0.509x
Cymat Technologies Ltd.
V:CYM
0.402x
Albion Resources Ltd
AU:ALB
-0.617x
Can Fite Biopharma Ltd
TA:CANF
-0.425x
Gulf Resources, Inc. (NV) Common Stock
NASDAQ:GURE
0.062x
FATHOM NICKEL INC.
F:6Q5
-0.001x
CARLSON INV. ZY 13
F:2HB
N/A

Annual Cash Flow Conversion Efficiency for Bio Green Med Solution, Inc. (2005–2025)

The table below shows the annual cash flow conversion efficiency of Bio Green Med Solution, Inc. from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see BGMS company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $6.84 Million $-4.77 Million -0.697x -118.97%
2024-12-31 $-2.17 Million $-7.99 Million 3.675x +113.85%
2023-12-31 $607.00K $-16.11 Million -26.544x -2504.15%
2022-12-31 $20.43 Million $-20.83 Million -1.019x -107.23%
2021-12-31 $37.69 Million $-18.54 Million -0.492x -106.19%
2020-12-31 $33.26 Million $-7.93 Million -0.239x +70.46%
2019-12-31 $11.70 Million $-9.45 Million -0.808x -84.07%
2018-12-31 $15.27 Million $-6.70 Million -0.439x -27.68%
2017-12-31 $21.77 Million $-7.48 Million -0.344x +51.33%
2016-12-31 $14.27 Million $-10.08 Million -0.706x +8.02%
2015-12-31 $18.84 Million $-14.46 Million -0.768x +10.97%
2014-12-31 $21.69 Million $-18.70 Million -0.862x -32.78%
2013-12-31 $28.02 Million $-18.20 Million -0.649x +45.97%
2012-12-31 $10.02 Million $-12.04 Million -1.202x -67.70%
2011-12-31 $19.50 Million $-13.98 Million -0.717x -11.35%
2010-12-31 $24.92 Million $-16.04 Million -0.644x +80.32%
2009-12-31 $4.64 Million $-15.19 Million -3.272x -125.82%
2008-12-31 $20.64 Million $-29.91 Million -1.449x -262.93%
2007-12-31 $57.97 Million $-23.14 Million -0.399x -6.70%
2006-12-31 $53.92 Million $-20.17 Million -0.374x +89.82%
2005-12-31 $4.12 Million $-15.14 Million -3.676x --

About Bio Green Med Solution, Inc.

NASDAQ:BGMS USA Biotechnology
Market Cap
$5.41 Million
Market Cap Rank
#28205 Global
#5557 in USA
Share Price
$0.98
Change (1 day)
+0.66%
52-Week Range
$0.83 - $5.95
All Time High
$5.95
About

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. The company was founded in 199… Read more